A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+3.56%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$126M
AUM Growth
+$126M
Cap. Flow
-$3.45M
Cap. Flow %
-2.74%
Top 10 Hldgs %
94.04%
Holding
17
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

1
CRSP icon
CRISPR Therapeutics
CRSP
$2.5M
2
SENS icon
Senseonics Holdings
SENS
$920K
3
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
$23.6K

Sector Composition

1 Healthcare 94.24%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$39M 31.01% 2,444,809 -157,005 -6% -$2.5M
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$31.3M 24.89% 1,300,432 -981 -0.1% -$23.6K
SIEN
3
DELISTED
Sientra, Inc.
SIEN
$21.3M 16.97% 2,199,012 – –
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$9.22M 7.33% 1,600,000 – –
CASC
5
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3.43M 2.73% 925,000 – –
IMDZ
6
DELISTED
Immune Design Corp.
IMDZ
$3.4M 2.71% 352,300 – –
TARA icon
7
Protara Therapeutics
TARA
$120M
$3.03M 2.41% 2,017,872 – –
CHMA
8
DELISTED
Chiasma, Inc. Common Stock
CHMA
$2.91M 2.32% 2,080,595 – –
CLLS
9
Cellectis
CLLS
$258M
$2.57M 2.04% 100,000 – –
DERM
10
DELISTED
Dermira, Inc.
DERM
$2.04M 1.62% 70,000 – –
EVAR
11
DELISTED
Lombard Medical, Inc.
EVAR
$1.81M 1.44% 3,473,452 – –
OCGN icon
12
Ocugen
OCGN
$319M
$1.58M 1.26% 888,889 – –
AUPH icon
13
Aurinia Pharmaceuticals
AUPH
$1.58B
$1.54M 1.23% 252,129 – –
INNL
14
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$1.22M 0.97% 537,235 – –
ADAP
15
Adaptimmune Therapeutics
ADAP
$15.6M
$1.13M 0.9% 250,000 – –
NOVN
16
DELISTED
Novan, Inc. Common Stock
NOVN
$215K 0.17% 53,367 – –
SENS icon
17
Senseonics Holdings
SENS
$374M
– – -516,882 Closed -$920K